Health Catalyst, Inc.
HCAT
$1.34
-$0.14-9.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.25% | -2.15% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.25% | -2.15% | |||
| Cost of Revenue | -0.86% | -5.62% | |||
| Gross Profit | -9.19% | 1.17% | |||
| SG&A Expenses | 4.46% | -13.97% | |||
| Depreciation & Amortization | -5.95% | 2.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.49% | -7.26% | |||
| Operating Income | -110.68% | 58.15% | |||
| Income Before Tax | -22.03% | -308.54% | |||
| Income Tax Expenses | 9.23% | 824.39% | |||
| Earnings from Continuing Operations | -21.97% | -309.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.97% | -309.49% | |||
| EBIT | -110.68% | 58.15% | |||
| EBITDA | -70.27% | 256.56% | |||
| EPS Basic | -19.29% | -305.86% | |||
| Normalized Basic EPS | -36.99% | 37.53% | |||
| EPS Diluted | -19.29% | -305.86% | |||
| Normalized Diluted EPS | -36.99% | 37.53% | |||
| Average Basic Shares Outstanding | 2.25% | 0.88% | |||
| Average Diluted Shares Outstanding | 2.25% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||